About CytRx Corporation

A biopharmaceutical company engaged in the development of high-value therapeutics utilizing its core technologies in small molecule drugs, RNAi drug discovery and DNA vaccines. CytRx is developing products based on three unique platforms: small molecule chaperone amplification, RNAi technology, and DNA vaccines in a variety of therapeutic indications including ALS, obesity, type 2 diabetes, HIV and cardiovascular disease.

About Pharma Finance 2007

A unique two-day intensive approach to find and to offer, in an international environment: AIC, Patents & Licensing, Co-Marketing of Bio-Nano-Pharma Technologies. Pharma Finance 2007 is not an arena-style conference. It is specifically designed to support in-depth partnership development.